Company: IXHL
Filing Date: 2025-03-10
Form Type: 8-K
Source: 0001213900-25-022279
Chunk: 2

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-10
Form: 8-K
Item: Item 1.01
Chunk 2
---
.

The
Purchase Agreement, Registration Rights Agreement and Placement Agreement contain representations and warranties, indemnification rights,
agreements and obligations. The Private Placement closed on March 10, 2025. The Company received approximately $11.3 million in net proceeds from the Private Placement, after deducting
Placement Agent fees and other expenses and prior to the repayment of convertible debentures. The Company intends to use the net proceeds
from the Private Placement to fund its ongoing clinical trials and research and development efforts. The proceeds will also be used for
the repayment of outstanding convertible debentures, as working capital, and for general corporate purposes.

The
Securities have not been registered under the Securities Act of 1933, as amended, and were offered pursuant to the exemption from registration
provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.

The foregoing summary of the terms and conditions of each of the Series
A Warrant, Pre-Funded Warrant, Securities Purchase Agreement, Registration Rights Agreement, Placement Agreement is subject to, and qualified
in its entirety by reference to the full text of such agreement, copies of which are filed as Exhibits 4.1, 4.2, 10.1, 10.2, and 10.3,
respectively, to this Current Report on Form 8-K and is incorporated herein by reference.

Item 3.02. Unregistered
Sales of Equity Securities.